{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:04:16Z","timestamp":1790395456060,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Palisaded neutrophilic and granulomatous dermatitis (PNGD) is a relatively rare histopathologic reaction pattern that has been associated with several underlying conditions including rheumatoid arthritis, connective tissue disorders, certain drugs, and hematologic malignancies, particularly chronic myelomonocytic leukemia (CMML). CMML shows features of a myeloproliferative neoplasm and myelodysplastic syndrome. The diagnosis can be supported by identifying an acquired clonal molecular abnormality, most commonly involving <jats:italic toggle=\"yes\">TET2, SRSF2, ASXL1, RUNX1, NRAS<\/jats:italic>, or <jats:italic toggle=\"yes\">CBL<\/jats:italic>. Rare previous reports have highlighted the association between PNGD and <jats:italic toggle=\"yes\">SRSF2<\/jats:italic>-mutated CMML. In this study, we report the first known case of PNGD-associated <jats:italic toggle=\"yes\">ASXL1<\/jats:italic>-mutated CMML without a coexistent <jats:italic toggle=\"yes\">SRSF2<\/jats:italic> variant.<\/jats:p>","DOI":"10.1097\/dad.0000000000003087","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T21:00:15Z","timestamp":1753995615000},"page":"882-885","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Palisaded Neutrophilic and Granulomatous Dermatitis Associated With ASXL1-Mutated Chronic Myelomonocytic Leukemia: A Case Report and Literature Review"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2059-6895","authenticated-orcid":false,"given":"Ibrahim","family":"Elsharawi","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Nova Scotia, Canada;"},{"name":"Division of Hematological Pathology, Dalhousie University, Nova Scotia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"DeCoste","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Nova Scotia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Dermatology, Nova Scotia, Canada; and"},{"name":"Maritime Dermatology, Nova Scotia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gillan","sequence":"additional","affiliation":[{"name":"Division of Hematological Pathology, Dalhousie University, Nova Scotia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Pasternak","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Nova Scotia, Canada;"},{"name":"Department of Medicine, Division of Dermatology, Nova Scotia, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"R1-20251020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jdcr.2017.06.010","article-title":"Palisaded neutrophilic granulomatous dermatitis: spectrum of histologic findings in a single patient","volume":"3","author":"Kalen","year":"2017","journal-title":"JAAD Case Rep"},{"key":"R2-20251020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.humpath.2017.04.010","article-title":"Generalized palisaded neutrophilic and granulomatous dermatitis-a cutaneous manifestation of chronic myelomonocytic leukemia? A clinical, histopathological, and molecular study of 3 cases","volume":"64","author":"Federmann","year":"2017","journal-title":"Hum Pathol."},{"key":"R3-20251020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ccr3.2072","article-title":"A case of palisaded neutrophilic granulomatous dermatitis with subsequent development of chronic myelomonocytic leukemia","volume":"7","author":"Kyriakou","year":"2019","journal-title":"Clin Case Rep."},{"key":"R4-20251020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.124620","article-title":"Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis","volume":"47","author":"Sangueza","year":"2002","journal-title":"J Am Acad Dermatol."},{"key":"R5-20251020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am J Hematol."},{"key":"R6-20251020","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/DAD.0000000000002085","article-title":"Unique recognizable histopathologic variant of palisaded neutrophilic and granulomatous dermatitis that is associated with SRSF2-Mutated chronic myelomonocytic leukemia: case report and review of the literature","volume":"44","author":"Enescu","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R7-20251020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000527461","article-title":"Underlying systemic diseases in interstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis: a systematic review","volume":"239","author":"Yang","year":"2023","journal-title":"Dermatology"},{"key":"R8-20251020","doi-asserted-by":"crossref","first-page":"2050313X20979560","DOI":"10.1177\/2050313X20979560","article-title":"Palisaded neutrophilic and granulomatous dermatitis following a long-standing monoclonal gammopathy: A case report","volume":"9","author":"Zabihi-Pour","year":"2021","journal-title":"SAGE Open Med Case Rep"},{"key":"R9-20251020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/DAD.0000000000001411","article-title":"Palisaded neutrophilic granulomatous dermatitis leading to diagnosis of hodgkin lymphoma: report of rare case and literature review of paraneoplastic granulomatous dermatitides","volume":"41","author":"Pei","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R11-20251020","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1182\/blood-2024-197986","article-title":"Estimating the prevalence of possible undiagnosed chronic myelomonocytic leukemia in the general population: an nhanes analysis","volume":"144","author":"Sastow","year":"2024","journal-title":"Blood"},{"key":"R12-20251020","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3324\/haematol.2021.279500","article-title":"How I diagnose and treat chronic myelomonocytic leukemia","volume":"107","author":"Patnaik","year":"2022","journal-title":"Haematologica"},{"key":"R13-20251020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41408-017-0004-0","article-title":"ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS","volume":"7","author":"Sallman","year":"2017","journal-title":"Blood Cancer J."},{"key":"R14-20251020","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1182\/blood-2022-170069","article-title":"RAS pathway mutations are associated with progression after hypomethylating agent therapy in chronic myelomonocytic leukemia","volume":"140","author":"Montalban-Bravo","year":"2022","journal-title":"Blood."},{"key":"R15-20251020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/10245332.2018.1471794","article-title":"Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis","volume":"23","author":"Arbab Jafari","year":"2018","journal-title":"Hematology."},{"key":"R16-20251020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D32WP4W6CZ","article-title":"Combination therapy with intralesional triamcinolone and oral dapsone for management of palisaded neutrophilic and granulomatous dermatitis","volume":"19","author":"He","year":"2013","journal-title":"Dermatol Online J."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T21:00:09Z","timestamp":1760994009000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003087","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}